Joseph Kash MD in Naperville, Illinois

Home Illinois Naperville

Joseph Kash MD has Hematology/oncology as his primary medical specialty. Their primary office is: 801 S Washington St in Naperville, Illinois. There is an additional office location, for a total of two, for Joseph Kash MD that can be viewed further down.

They're a part of the: Edward Health Ventures medical group which has around 519 members. You can call their office at - to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Illinois College Of Med (chi/peor/rock/chm-urb) and graduated in 1993 (around 31 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Joseph J Kash MD Office Phone and Directions

Joseph Kash MD
Edward Health Ventures
801 S Washington St
Naperville, Illinois 60540
-

Patient Ratings
Please rate your experience with Joseph Kash MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Enter a starting address:

Healthcare Info for Joseph Kash MD

Medical School: University Of Illinois College Of Med (chi/peor/rock/chm-urb)
Graduation Year: 1993
The Primary Medical Specialty for Joseph Kash MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 31
PAC (PECOS ID)#: 9032182340
NPI #: 1043297971
NPI Created On: 12/30/2005
NPI Last Updated Listed as: 04/02/2013
Primary Taxonomy Code: 207RH0003X
License Number:
36091682
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Celtic Insurance Company
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Physician telephone patient service, 5-10 minutes of medical discussion
Physician telephone patient service, 11-20 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $106

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818576415

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818579647

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $1

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819156863

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $106

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819177219

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $14

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783654899

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835932707

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: Phesgo

Open Associated Drug #1: 50242-245-01

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812742637

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: LUTATHERA

Open Associated Drug #1: 69488-003-01

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 826368793

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: LUMAKRAS

Open Associated Drug #1: 55513-488-02

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2782864;EPRINTS;10590485

Record ID:: 845874841

Being Disputed:: No

Product Related: Yes

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 851044971

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Xermelo

Open Associated Drug #1: 70183-125-85

Additional Office Locations

1. Edward Health Ventures
120 Spalding Dr
Naperville, IL 60540
Group Members: 519

Enter a starting address:

Hematology/oncology Professionals in Naperville

1.
William Broderick

801 S Washington St
Naperville, IL
Edward Health Ventures

2.
William Broderick

120 Spalding Dr
Naperville, IL
Edward Health Ventures

3.
Matthew Siegel

120 Spalding Dr
Naperville, IL
Edward Health Ventures

4.
Samir Undevia MD

801 S Washington St
Naperville, IL
Edward Health Ventures

5.
Samir Undevia MD

120 Spalding Dr
Naperville, IL
Edward Health Ventures

6.
Maria Quejada MD

801 S Washington St
Naperville, IL
Edward Health Ventures

Providers in Edward Health Ventures

1.Jon Aagaard

1200 S York St
Elmhurst Il 60126-5632
Edward Health Ventures
Family Practice

2.Ramez Abdalla

120 Spalding Dr
Naperville Il 60540-6599
Edward Health Ventures
Diagnostic Radiology

3.Ramez Abdalla

801 S Washington St
Naperville Il 60540-7430
Edward Health Ventures
Diagnostic Radiology

4.Mary Adams

303 W Lake St
Addison Il 60101-2565
Edward Health Ventures
Nurse Practitioner

5.Mary Adams

6701 Us Hwy 34
Oswego Il 60543-9129
Edward Health Ventures
Nurse Practitioner

6.George Aghia

2007 95th St
Naperville Il 60564-7802
Edward Health Ventures
Family Practice

View all 519 members of Edward Health Ventures medical group